{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HILI", "hepatotoxicity", "herb", "herb-ingredient network", "mechanism", "phylogenetic tree", "structure-toxicity relationship"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31349548", "DateCompleted": {"Year": "2020", "Month": "01", "Day": "02"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "25"}], "Language": ["eng"], "ELocationID": ["3633", "10.3390/ijms20153633"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "20", "Issue": "15", "PubDate": {"Year": "2019", "Month": "Jul", "Day": "25"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis.", "Abstract": {"AbstractText": ["Currently, hundreds of herbal products with potential hepatotoxicity were available in the literature. A comprehensive summary and analysis focused on these potential hepatotoxic herbal products may assist in understanding herb-induced liver injury (HILI). In this work, we collected 335 hepatotoxic medicinal plants, 296 hepatotoxic ingredients, and 584 hepatoprotective ingredients through a systematic literature retrieval. Then we analyzed these data from the perspectives of phylogenetic relationship and structure-toxicity relationship. Phylogenetic analysis indicated that hepatotoxic medicinal plants tended to have a closer taxonomic relationship. By investigating the structures of the hepatotoxic ingredients, we found that alkaloids and terpenoids were the two major groups of hepatotoxicity. We also identified eight major skeletons of hepatotoxicity and reviewed their hepatotoxic mechanisms. Additionally, 15 structural alerts (SAs) for hepatotoxicity were identified based on SARpy software. These SAs will help to estimate the hepatotoxic risk of ingredients from herbs. Finally, a herb-ingredient network was constructed by integrating multiple datasets, which will assist to identify the hepatotoxic ingredients of herb/herb-formula quickly. In summary, a systemic analysis focused on HILI was conducted which will not only assist to identify the toxic molecular basis of hepatotoxic herbs but also contribute to decipher the mechanisms of HILI."]}, "AuthorList": [{"Identifier": ["0000-0003-0302-7332"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China."}], "LastName": "He", "ForeName": "Shuaibing", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China."}], "LastName": "Zhang", "ForeName": "Chenyang", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China."}], "LastName": "Zhou", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China."}], "LastName": "Zhang", "ForeName": "Xuelian", "Initials": "X"}, {"Identifier": ["0000-0003-2537-6461"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China."}], "LastName": "Ye", "ForeName": "Tianyuan", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China."}], "LastName": "Wang", "ForeName": "Ruiying", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China. gbsun@implad.ac.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China. gbsun@implad.ac.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China. gbsun@implad.ac.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China. gbsun@implad.ac.cn."}], "LastName": "Sun", "ForeName": "Guibo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China. xbsun@implad.ac.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing 100193, China. xbsun@implad.ac.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Efficacy Evaluation of Chinese Medicine against Glycolipid Metabolic Disorders, State Administration of Traditional Chinese Medicine, Beijing 100193, China. xbsun@implad.ac.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of new drug discovery based on Classic Chinese medicine prescription, Chinese Academy of Medical Sciences, Beijing 100193, China. xbsun@implad.ac.cn."}], "LastName": "Sun", "ForeName": "Xiaobo", "Initials": "X"}], "GrantList": [{"GrantID": "2015ZX09501004-001-003", "Agency": "National Science and Technology Major Project", "Country": ""}, {"GrantID": "2017ZX09301069", "Agency": "National Science and Technology Major Project", "Country": ""}, {"GrantID": "201507004", "Agency": "Special Research Project for TCM", "Country": ""}, {"GrantID": "2016-I2M-1-012", "Agency": "the CAMS Innovation Fund for Medical Sciences (CIFMS)", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["etiology", "metabolism"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Neural Networks, Computer"}, {"QualifierName": [], "DescriptorName": "Phylogeny"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["adverse effects", "analysis", "chemistry"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["chemistry", "classification", "genetics"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 2005;4:489\u2013499. doi: 10.1038/nrd1750.", "ArticleIdList": ["10.1038/nrd1750", "15931258"]}, {"Citation": "Navarro V.J., Senior J.R. Drug-related hepatotoxicity. N. Engl. J. Med. 2006;354:731\u2013739. doi: 10.1056/NEJMra052270.", "ArticleIdList": ["10.1056/NEJMra052270", "16481640"]}, {"Citation": "Hebels D.G., Jetten M.J., Aerts H.J., Herwig R., Theunissen D.H., Gaj S., van Delft J.H., Kleinjans J.C. Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. Biomark. Med. 2014;8:185\u2013200. doi: 10.2217/bmm.13.154.", "ArticleIdList": ["10.2217/bmm.13.154", "24521014"]}, {"Citation": "Hoofnagle J.H., Serrano J., Knoben J.E., Navarro V.J. LiverTox: A website on drug-induced liver injury. Hepatology. 2013;57:873\u2013874. doi: 10.1002/hep.26175.", "ArticleIdList": ["10.1002/hep.26175", "PMC5044298", "23456678"]}, {"Citation": "Russmann S., Kullak-Ublick G.A., Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr. Med. Chem. 2009;16:3041\u20133053. doi: 10.2174/092986709788803097.", "ArticleIdList": ["10.2174/092986709788803097", "PMC2765083", "19689281"]}, {"Citation": "Siramshetty V.B., Nickel J., Omieczynski C., Gohlke B.O., Drwal M.N., Preissner R. WITHDRAWN\u2014A resource for withdrawn and discontinued drugs. Nucleic Acids Res. 2016;44:D1080\u2013D1086. doi: 10.1093/nar/gkv1192.", "ArticleIdList": ["10.1093/nar/gkv1192", "PMC4702851", "26553801"]}, {"Citation": "Prabhakar A., Kaiser J.M., Novitch M.B., Cornett E.M., Urman R.D., Kaye A.D. The Role of Complementary and Alternative Medicine Treatments in Fibromyalgia: A Comprehensive Review. Curr. Rheumatol. Rep. 2019;21:14. doi: 10.1007/s11926-019-0814-0.", "ArticleIdList": ["10.1007/s11926-019-0814-0", "30830504"]}, {"Citation": "Jeong S.M., Seo B.K., Park Y.C., Baek Y.H. A Review of Complementary and Alternative Medicine Therapies on Muscular Atrophy: A Literature Review of In Vivo/In Vitro Studies. Evid. Based Complement. Altern. Med. Ecam. 2018;2018:8654719. doi: 10.1155/2018/8654719.", "ArticleIdList": ["10.1155/2018/8654719", "PMC6276427", "30581489"]}, {"Citation": "Terhorst L., Schneider M.J., Kim K.H., Goozdich L.M., Stilley C.S. Complementary and alternative medicine in the treatment of pain in fibromyalgia: A systematic review of randomized controlled trials. J. Manip. Physiol. Ther. 2011;34:483\u2013496. doi: 10.1016/j.jmpt.2011.05.006.", "ArticleIdList": ["10.1016/j.jmpt.2011.05.006", "21875523"]}, {"Citation": "Seeff L.B., Lindsay K.L., Bacon B.R., Kresina T.F., Hoofnagle J.H. Complementary and alternative medicine in chronic liver disease. Hepatology. 2001;34:595\u2013603. doi: 10.1053/jhep.2001.27445.", "ArticleIdList": ["10.1053/jhep.2001.27445", "11526548"]}, {"Citation": "Philippou Y., Hadjipavlou M., Khan S., Rane A. Complementary and alternative medicine (CAM) in prostate and bladder cancer. BJU Int. 2013;112:1073\u20131079. doi: 10.1111/bju.12062.", "ArticleIdList": ["10.1111/bju.12062", "23944379"]}, {"Citation": "Xu W., Zou Z., Pei J., Huang L. Longitudinal trend of global artemisinin research in chemistry subject areas (1983\u20132017) Bioorg. Med. Chem. 2018;26:5379\u20135387. doi: 10.1016/j.bmc.2018.09.030.", "ArticleIdList": ["10.1016/j.bmc.2018.09.030", "30279043"]}, {"Citation": "Wishart D.S., Feunang Y.D., Guo A.C., Lo E.J., Marcu A., Grant J.R., Sajed T., Johnson D., Li C., Sayeeda Z., et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074\u2013D1082. doi: 10.1093/nar/gkx1037.", "ArticleIdList": ["10.1093/nar/gkx1037", "PMC5753335", "29126136"]}, {"Citation": "Afolabi S.O., Akindele A.J., Awodele O., Anunobi C.C., Adeyemi O.O. A 90 day chronic toxicity study of Nigerian herbal preparation DAS-77 in rats. BMC Complement. Altern. Med. 2012;12:79. doi: 10.1186/1472-6882-12-79.", "ArticleIdList": ["10.1186/1472-6882-12-79", "PMC3522554", "22892317"]}, {"Citation": "Abdualmjid R.J., Sergi C. Hepatotoxic botanicals\u2014An evidence-based systematic review. J. Pharm. Pharm. Sci. 2013;16:376\u2013404. doi: 10.18433/J36G6X.", "ArticleIdList": ["10.18433/J36G6X", "24021288"]}, {"Citation": "Shen T., Liu Y., Shang J., Xie Q., Li J., Yan M., Xu J., Niu J., Liu J., Watkins P.B., et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019;156:2230\u20132241. doi: 10.1053/j.gastro.2019.02.002.", "ArticleIdList": ["10.1053/j.gastro.2019.02.002", "30742832"]}, {"Citation": "Byeon J.H., Kil J.H., Ahn Y.C., Son C.G. Systematic review of published data on herb induced liver injury. J. Ethnopharmacol. 2019;233:190\u2013196. doi: 10.1016/j.jep.2019.01.006.", "ArticleIdList": ["10.1016/j.jep.2019.01.006", "30639232"]}, {"Citation": "Wu L., Han W., Chen Y., Zhang T., Liu J., Zhong S., Liu H., Han C., Zhang Z., Liu S., et al. Gender Differences in the Hepatotoxicity and Toxicokinetics of Emodin: The Potential Mechanisms Mediated by UGT2B7 and MRP2. Mol. Pharm. 2018;15:3931\u20133945. doi: 10.1021/acs.molpharmaceut.8b00387.", "ArticleIdList": ["10.1021/acs.molpharmaceut.8b00387", "30011215"]}, {"Citation": "George N., Chen M., Yuen N., Hunt C.M., Suzuki A. Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. Regul. Toxicol. Pharmacol. 2018;94:101\u2013107. doi: 10.1016/j.yrtph.2018.01.018.", "ArticleIdList": ["10.1016/j.yrtph.2018.01.018", "29407200"]}, {"Citation": "Vaughan N., Tweed J., Greenwell C., Notrica D.M., Langlais C.S., Peter S.D., Leys C.M., Ostlie D.J., Maxson R.T., Ponsky T., et al. The impact of morbid obesity on solid organ injury in children using the ATOMAC protocol at a pediatric level I trauma center. J. Pediatr. Surg. 2017;52:345\u2013348. doi: 10.1016/j.jpedsurg.2016.09.002.", "ArticleIdList": ["10.1016/j.jpedsurg.2016.09.002", "27707653"]}, {"Citation": "Ahmad J., Odin J.A. Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity. Clin. Liver Dis. 2017;21:55\u201372. doi: 10.1016/j.cld.2016.08.004.", "ArticleIdList": ["10.1016/j.cld.2016.08.004", "PMC8290403", "27842775"]}, {"Citation": "Devarbhavi H., Singh R., Patil M., Sheth K., Adarsh C.K., Balaraju G. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. J. Gastroenterol. Hepatol. 2013;28:161\u2013167. doi: 10.1111/j.1440-1746.2012.07279.x.", "ArticleIdList": ["10.1111/j.1440-1746.2012.07279.x", "23020522"]}, {"Citation": "Chen M., Borlak J., Tong W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology. 2013;58:388\u2013396. doi: 10.1002/hep.26208.", "ArticleIdList": ["10.1002/hep.26208", "23258593"]}, {"Citation": "Sasaki E., Yokoi T. Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries. J. Toxicol. Sci. 2018;43:75\u201387. doi: 10.2131/jts.43.75.", "ArticleIdList": ["10.2131/jts.43.75", "29479037"]}, {"Citation": "Corsini A., Bortolini M. Drug-induced liver injury: The role of drug metabolism and transport. J. Clin. Pharmacol. 2013;53:463\u2013474. doi: 10.1002/jcph.23.", "ArticleIdList": ["10.1002/jcph.23", "23436293"]}, {"Citation": "Wai C.T., Tan B.H., Chan C.L., Sutedja D.S., Lee Y.M., Khor C., Lim S.G. Drug-induced liver injury at an Asian center: A prospective study. Liver Int. 2007;27:465\u2013474. doi: 10.1111/j.1478-3231.2007.01461.x.", "ArticleIdList": ["10.1111/j.1478-3231.2007.01461.x", "17403186"]}, {"Citation": "Philips C.A., Augustine P., Rajesh S., John S.K., Valiathan G.C., Mathew J., Phalke S., Antony K.L. Slimming to the Death: Herbalife(R)-Associated Fatal Acute Liver Failure-Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India. J. Clin. Exp. Hepatol. 2019;9:268\u2013272. doi: 10.1016/j.jceh.2018.08.002.", "ArticleIdList": ["10.1016/j.jceh.2018.08.002", "PMC6477126", "31024209"]}, {"Citation": "Philips C.A., Paramaguru R., Joy A.K., Antony K.L., Augustine P. Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury\u2014A single-center experience from southern India. Indian J. Gastroenterol. 2018;37:9\u201317. doi: 10.1007/s12664-017-0815-8.", "ArticleIdList": ["10.1007/s12664-017-0815-8", "29476406"]}, {"Citation": "Wang J., Ma Z., Niu M., Zhu Y., Liang Q., Zhao Y., Song J., Bai Z., Zhang Y., Zhang P., et al. Evidence chain-based causality identification in herb-induced liver injury: Exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front. Med. 2015;9:457\u2013467. doi: 10.1007/s11684-015-0417-8.", "ArticleIdList": ["10.1007/s11684-015-0417-8", "26459430"]}, {"Citation": "Tseng A., Wong D.K. Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients. J. Hepatol. 2016;65:651\u2013653. doi: 10.1016/j.jhep.2016.05.015.", "ArticleIdList": ["10.1016/j.jhep.2016.05.015", "27210428"]}, {"Citation": "Parvez M.K., Rishi V. Herb-Drug Interactions and Hepatotoxicity. Curr. Drug Metab. 2019;20:275\u2013282. doi: 10.2174/1389200220666190325141422.", "ArticleIdList": ["10.2174/1389200220666190325141422", "30914020"]}, {"Citation": "Vinken M., Maes M., Vanhaecke T., Rogiers V. Drug-induced liver injury: Mechanisms, types and biomarkers. Curr. Med. Chem. 2013;20:3011\u20133021. doi: 10.2174/0929867311320240006.", "ArticleIdList": ["10.2174/0929867311320240006", "23746274"]}, {"Citation": "Mulliner D., Schmidt F., Stolte M., Spirkl H.P., Czich A., Amberg A. Computational Models for Human and Animal Hepatotoxicity with a Global Application Scope. Chem. Res. Toxicol. 2016;29:757\u2013767. doi: 10.1021/acs.chemrestox.5b00465.", "ArticleIdList": ["10.1021/acs.chemrestox.5b00465", "26914516"]}, {"Citation": "Holt M.P., Ju C. Mechanisms of drug-induced liver injury. AAPS J. 2006;8:E48\u2013E54. doi: 10.1208/aapsj080106.", "ArticleIdList": ["10.1208/aapsj080106", "PMC2751423", "16584133"]}, {"Citation": "Maddrey W.C. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver. Gastroenterology. 1999;118:984\u2013985. doi: 10.1016/S0016-5085(00)70192-2.", "ArticleIdList": ["10.1016/S0016-5085(00)70192-2"]}, {"Citation": "Melo-Filho C.C., Braga R.C., Andrade C.H. Advances in methods for predicting phase I metabolism of polyphenols. Curr. Drug Metab. 2014;15:120\u2013126. doi: 10.2174/1389200215666140130125339.", "ArticleIdList": ["10.2174/1389200215666140130125339", "24479689"]}, {"Citation": "Lo Y.C., Rensi S.E., Torng W., Altman R.B. Machine learning in chemoinformatics and drug discovery. Drug Discov. Today. 2018;23:1538\u20131546. doi: 10.1016/j.drudis.2018.05.010.", "ArticleIdList": ["10.1016/j.drudis.2018.05.010", "PMC6078794", "29750902"]}, {"Citation": "Kar S., Leszczynski J. Exploration of Computational Approaches to Predict the Toxicity of Chemical Mixtures. Toxics. 2019;7:15. doi: 10.3390/toxics7010015.", "ArticleIdList": ["10.3390/toxics7010015", "PMC6468900", "30893892"]}, {"Citation": "Zhang L., Zhang H., Ai H., Hu H., Li S., Zhao J., Liu H. Applications of Machine Learning Methods in Drug Toxicity Prediction. Curr. Top. Med. Chem. 2018;18:987\u2013997. doi: 10.2174/1568026618666180727152557.", "ArticleIdList": ["10.2174/1568026618666180727152557", "30051792"]}, {"Citation": "Martin T.M., Harten P., Young D.M., Muratov E.N., Golbraikh A., Zhu H., Tropsha A. Does rational selection of training and test sets improve the outcome of QSAR modeling? J. Chem. Inf. Model. 2012;52:2570\u20132578. doi: 10.1021/ci300338w.", "ArticleIdList": ["10.1021/ci300338w", "23030316"]}, {"Citation": "Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv. Drug Deliv. Rev. 2012;64:480\u2013495. doi: 10.1016/j.addr.2011.10.009.", "ArticleIdList": ["10.1016/j.addr.2011.10.009", "22265844"]}, {"Citation": "Tyzack J.D., Kirchmair J. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery. Chem. Biol. Drug Des. 2019;93:377\u2013386. doi: 10.1111/cbdd.13445.", "ArticleIdList": ["10.1111/cbdd.13445", "PMC6590657", "30471192"]}, {"Citation": "Johnston H.J., Hutchison G.R., Christensen F.M., Aschberger K., Stone V. The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol. Sci. 2010;114:162\u2013182. doi: 10.1093/toxsci/kfp265.", "ArticleIdList": ["10.1093/toxsci/kfp265", "19901017"]}, {"Citation": "Reimann A., Nurhayati N., Backenkohler A., Ober D. Repeated evolution of the pyrrolizidine alkaloid-mediated defense system in separate angiosperm lineages. Plant. Cell. 2004;16:2772\u20132784. doi: 10.1105/tpc.104.023176.", "ArticleIdList": ["10.1105/tpc.104.023176", "PMC520970", "15466410"]}, {"Citation": "Schoental R. Hepatotoxic action of pyrrolizidine (Senecio) alkaloids in relation to their structure. Nature. 1957;179:361\u2013363. doi: 10.1038/179361a0.", "ArticleIdList": ["10.1038/179361a0", "13407722"]}, {"Citation": "Mattocks A.R., White I.N. Pyrrolic metabolites from non-toxic pyrrolizidine alkaloids. Nat. New Biol. 1971;231:114\u2013115. doi: 10.1038/newbio231114a0.", "ArticleIdList": ["10.1038/newbio231114a0", "5281186"]}, {"Citation": "McLean E.K. The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharm. Rev. 1970;22:429\u2013483.", "ArticleIdList": ["4921839"]}, {"Citation": "Tu M., Li L., Lei H., Ma Z., Chen Z., Sun S., Xu S., Zhou H., Zeng S., Jiang H. Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity. Toxicology. 2014;322:34\u201342. doi: 10.1016/j.tox.2014.04.007.", "ArticleIdList": ["10.1016/j.tox.2014.04.007", "24799337"]}, {"Citation": "Yang M., Ruan J., Fu P.P., Lin G. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Chem. Biol. Interact. 2016;243:119\u2013126. doi: 10.1016/j.cbi.2015.09.011.", "ArticleIdList": ["10.1016/j.cbi.2015.09.011", "26365561"]}, {"Citation": "Zhu L., Xue J., Xia Q., Fu P.P., Lin G. The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: Kinetic study following single and multiple exposures in male ICR mice. Arch. Toxicol. 2017;91:949\u2013965. doi: 10.1007/s00204-016-1713-z.", "ArticleIdList": ["10.1007/s00204-016-1713-z", "27125825"]}, {"Citation": "Yang M., Ruan J., Gao H., Li N., Ma J., Xue J., Ye Y., Fu P.P., Wang J., Lin G. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Arch. Toxicol. 2017;91:3913\u20133925. doi: 10.1007/s00204-017-2013-y.", "ArticleIdList": ["10.1007/s00204-017-2013-y", "28620673"]}, {"Citation": "Yan X., Kang H., Feng J., Yang Y., Tang K., Zhu R., Yang L., Wang Z., Cao Z. Identification of Toxic Pyrrolizidine Alkaloids and Their Common Hepatotoxicity Mechanism. Int. J. Mol. Sci. 2016;17:318. doi: 10.3390/ijms17030318.", "ArticleIdList": ["10.3390/ijms17030318", "PMC4813181", "26959016"]}, {"Citation": "Neuman M.G., Cohen L., Opris M., Nanau R.M., Hyunjin J. Hepatotoxicity of Pyrrolizidine Alkaloids. J. Pharm. Pharm. Sci. 2015;18:825\u2013843. doi: 10.18433/J3BG7J.", "ArticleIdList": ["10.18433/J3BG7J", "26626258"]}, {"Citation": "Pramod K., Ansari S.H., Ali J. Eugenol: A natural compound with versatile pharmacological actions. Nat. Prod. Commun. 2010;5:1999\u20132006. doi: 10.1177/1934578X1000501236.", "ArticleIdList": ["10.1177/1934578X1000501236", "21299140"]}, {"Citation": "Mizutani T., Satoh K., Nomura H., Nakanishi K. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine. Res. Commun. Chem. Pathol. Pharmacol. 1991;71:219\u2013230.", "ArticleIdList": ["2047567"]}, {"Citation": "Bodell W.J., Ye Q., Pathak D.N., Pongracz K. Oxidation of eugenol to form DNA adducts and 8-hydroxy-2\u2019-deoxyguanosine: Role of quinone methide derivative in DNA adduct formation. Carcinogenesis. 1998;19:437\u2013443. doi: 10.1093/carcin/19.3.437.", "ArticleIdList": ["10.1093/carcin/19.3.437", "9525278"]}, {"Citation": "Yang A.H., Zhang L., Zhi D.X., Liu W.L., Gao X., He X. Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole. Xenobiotica. 2018;48:1164\u20131172. doi: 10.1080/00498254.2017.1399227.", "ArticleIdList": ["10.1080/00498254.2017.1399227", "29082813"]}, {"Citation": "Chung Y.T., Chen C.L., Wu C.C., Chan S.A., Chi C.W., Liu T.Y. Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing. Toxicol. Lett. 2008;183:21\u201327. doi: 10.1016/j.toxlet.2008.09.013.", "ArticleIdList": ["10.1016/j.toxlet.2008.09.013", "18938230"]}, {"Citation": "Murray M. Toxicological actions of plant-derived and anthropogenic methylenedioxyphenyl-substituted chemicals in mammals and insects. J. Toxicol. Environ. Health B Crit. Rev. 2012;15:365\u2013395. doi: 10.1080/10937404.2012.705105.", "ArticleIdList": ["10.1080/10937404.2012.705105", "22934566"]}, {"Citation": "Chellian R., Pandy V., Mohamed Z. Pharmacology and toxicology of alpha- and beta-Asarone: A review of preclinical evidence. Phytomedicine. 2017;32:41\u201358. doi: 10.1016/j.phymed.2017.04.003.", "ArticleIdList": ["10.1016/j.phymed.2017.04.003", "28732807"]}, {"Citation": "Lopez M.L., Hernandez A., Chamorro G., Mendoza-Figueroa T. alpha-Asarone toxicity in long-term cultures of adult rat hepatocytes. Planta Med. 1993;59:115\u2013120. doi: 10.1055/s-2006-959624.", "ArticleIdList": ["10.1055/s-2006-959624", "8488189"]}, {"Citation": "Patel D.N., Ho H.K., Tan L.L., Tan M.M., Zhang Q., Low M.Y., Chan C.L., Koh H.L. Hepatotoxic potential of asarones: In vitro evaluation of hepatotoxicity and quantitative determination in herbal products. Front. Pharmacol. 2015;6:25. doi: 10.3389/fphar.2015.00025.", "ArticleIdList": ["10.3389/fphar.2015.00025", "PMC4335289", "25750624"]}, {"Citation": "Choy C.S., Cheah K.P., Chiou H.Y., Li J.S., Liu Y.H., Yong S.F., Chiu W.T., Liao J.W., Hu C.M. Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration. J. Appl. Toxicol. 2008;28:945\u2013956. doi: 10.1002/jat.1360.", "ArticleIdList": ["10.1002/jat.1360", "18548746"]}, {"Citation": "Li L., Tu M., Yang X., Sun S., Wu X., Zhou H., Zeng S., Jiang H. The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity. Drug Metab. Dispos. 2014;42:1227\u20131234. doi: 10.1124/dmd.113.056689.", "ArticleIdList": ["10.1124/dmd.113.056689", "24778366"]}, {"Citation": "Ouyang C.B., Liu X.M., Liu Q., Bai J., Li H.Y., Li Y., Wang Q.X., Yan D.D., Mao L.G., Cao A., et al. Toxicity Assessment of Cadinene Sesquiterpenes from Eupatorium adenophorum in Mice. Nat. Prod. Bioprospect. 2014;5:29\u201336. doi: 10.1007/s13659-014-0050-2.", "ArticleIdList": ["10.1007/s13659-014-0050-2", "PMC4327999", "25500813"]}, {"Citation": "Wang Y., Lei H.P. Hepatotoxicity of gossypol in rats. J. Ethnopharmacol. 1987;20:53\u201364.", "ArticleIdList": ["3626595"]}, {"Citation": "Tang C., Zhang K., Zhan T., Zhao Q., Zhang J. Metabolic Characterization of Dairy Cows Treated with Gossypol by Blood Biochemistry and Body Fluid Untargeted Metabolome Analyses. J. Agric. Food Chem. 2017;65:9369\u20139378. doi: 10.1021/acs.jafc.7b03544.", "ArticleIdList": ["10.1021/acs.jafc.7b03544", "28965405"]}, {"Citation": "Manabe S., Nuber D.C., Lin Y.C. Zone-specific hepatotoxicity of gossypol in perfused rat liver. Toxicon. 1991;29:787\u2013790. doi: 10.1016/0041-0101(91)90071-X.", "ArticleIdList": ["10.1016/0041-0101(91)90071-X", "1926180"]}, {"Citation": "Fonseca N.B., Gadelha I.C., Oloris S.C., Soto-Blanco B. Effectiveness of albumin-conjugated gossypol as an immunogen to prevent gossypol-associated acute hepatotoxicity in rats. Food Chem. Toxicol. 2013;56:149\u2013153. doi: 10.1016/j.fct.2013.02.010.", "ArticleIdList": ["10.1016/j.fct.2013.02.010", "23485613"]}, {"Citation": "Gordon W.P., Forte A.J., McMurtry R.J., Gal J., Nelson S.D. Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse. Toxicol. Appl. Pharmacol. 1982;65:413\u2013424. doi: 10.1016/0041-008X(82)90387-8.", "ArticleIdList": ["10.1016/0041-008X(82)90387-8", "7157374"]}, {"Citation": "Gordon W.P., Huitric A.C., Seth C.L., McClanahan R.H., Nelson S.D. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran. Drug Metab. Dispos. 1987;15:589\u2013594.", "ArticleIdList": ["2891472"]}, {"Citation": "Zarybnicky T., Matouskova P., Lancosova B., Subrt Z., Skalova L., Bousova I. Inter-Individual Variability in Acute Toxicity of R-Pulegone and R-Menthofuran in Human Liver Slices and Their Influence on miRNA Expression Changes in Comparison to Acetaminophen. Int. J. Mol. Sci. 2018;19:1805. doi: 10.3390/ijms19061805.", "ArticleIdList": ["10.3390/ijms19061805", "PMC6032148", "29921785"]}, {"Citation": "Jodynis-Liebert J., Murias M., Bloszyk E. Effect of several sesquiterpene lactones on lipid peroxidation and glutathione level. Planta Med. 1999;65:320\u2013324. doi: 10.1055/s-1999-13994.", "ArticleIdList": ["10.1055/s-1999-13994", "10364836"]}, {"Citation": "Jodynis-Liebert J., Murias M., Bloszyk E. Effect of sesquiterpene lactones on antioxidant enzymes and some drug-metabolizing enzymes in rat liver and kidney. Planta Med. 2000;66:199\u2013205. doi: 10.1055/s-2000-8566.", "ArticleIdList": ["10.1055/s-2000-8566", "10821042"]}, {"Citation": "Merrill J.C., Kim H.L., Safe S., Murray C.A., Hayes M.A. Role of glutathione in the toxicity of the sesquiterpene lactones hymenoxon and helenalin. J. Toxicol. Environ. Health. 1988;23:159\u2013169. doi: 10.1080/15287398809531103.", "ArticleIdList": ["10.1080/15287398809531103", "3343693"]}, {"Citation": "Matsuda H., Morikawa T., Toguchida I., Ninomiya K., Yoshikawa M. Medicinal foodstuffs. XXVIII. Inhibitors of nitric oxide production and new sesquiterpenes, zedoarofuran, 4-epicurcumenol, neocurcumenol, gajutsulactones A and B, and zedoarolides A and B, from Zedoariae Rhizoma. Chem. Pharm. Bull. 2001;49:1558\u20131566. doi: 10.1248/cpb.49.1558.", "ArticleIdList": ["10.1248/cpb.49.1558", "11767075"]}, {"Citation": "Matsuda H., Ninomiya K., Morikawa T., Yoshikawa M. Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury. Bioorg. Med. Chem. Lett. 1998;8:339\u2013344. doi: 10.1016/S0960-894X(98)00021-3.", "ArticleIdList": ["10.1016/S0960-894X(98)00021-3", "9871681"]}, {"Citation": "Yang X., Zhang Y., Liu Y., Chen C., Xu W., Xiao H. Emodin induces liver injury by inhibiting the key enzymes of FADH/NADPH transport in rat liver. Toxicol. Res. 2018;7:888\u2013896. doi: 10.1039/C7TX00307B.", "ArticleIdList": ["10.1039/C7TX00307B", "PMC6116728", "30310665"]}, {"Citation": "Dong X., Ni B., Fu J., Yin X., You L., Leng X., Liang X., Ni J. Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspasedependent pathway. Oncol. Rep. 2018;40:1985\u20131993.", "ArticleIdList": ["PMC6111625", "30106438"]}, {"Citation": "Jiang L.L., Jiang Y., Zhao D.S., Fan Y.X., Yu Q., Li P., Li H.J. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury. Chem. Res. Toxicol. 2018;31:1052\u20131060. doi: 10.1021/acs.chemrestox.8b00117.", "ArticleIdList": ["10.1021/acs.chemrestox.8b00117", "30203651"]}, {"Citation": "Lin L., Liu Y., Fu S., Qu C., Li H., Ni J. Inhibition of Mitochondrial Complex Function-The Hepatotoxicity Mechanism of Emodin Based on Quantitative Proteomic Analyses. Cells. 2019;8:263. doi: 10.3390/cells8030263.", "ArticleIdList": ["10.3390/cells8030263", "PMC6468815", "30897821"]}, {"Citation": "He L.N., Yang A.H., Cui T.Y., Zhai Y.R., Zhang F.L., Chen J.X., Jin C.H., Fan Y.W., Wu Z.J., Wang L.L., et al. Reactive metabolite activation by CYP2C19-mediated rhein hepatotoxicity. Xenobiotica. 2015;45:361\u2013372. doi: 10.3109/00498254.2014.984794.", "ArticleIdList": ["10.3109/00498254.2014.984794", "25815638"]}, {"Citation": "KoraMagazi A., Wang D., Yousef B., Guerram M., Yu F. Rhein triggers apoptosis via induction of endoplasmic reticulum stress, caspase-4 and intracellular calcium in primary human hepatic HL-7702 cells. Biochem. Biophys. Res. Commun. 2016;473:230\u2013236. doi: 10.1016/j.bbrc.2016.03.084.", "ArticleIdList": ["10.1016/j.bbrc.2016.03.084", "27003256"]}, {"Citation": "You L., Dong X., Yin X., Yang C., Leng X., Wang W., Ni J. Rhein Induces Cell Death in HepaRG Cells through Cell Cycle Arrest and Apoptotic Pathway. Int. J. Mol. Sci. 2018;19:1060. doi: 10.3390/ijms19041060.", "ArticleIdList": ["10.3390/ijms19041060", "PMC5979559", "29614833"]}, {"Citation": "Kang L., Si L., Rao J., Li D., Wu Y., Wu S., Wu M., He S., Zhu W., Wu Y., et al. Polygoni Multiflori Radix derived anthraquinones alter bile acid disposition in sandwich-cultured rat hepatocytes. Toxicol. In Vitro. 2017;40:313\u2013323. doi: 10.1016/j.tiv.2017.01.022.", "ArticleIdList": ["10.1016/j.tiv.2017.01.022", "28161596"]}, {"Citation": "Dong X., Fu J., Yin X., Qu C., Yang C., He H., Ni J. Induction of Apoptosis in HepaRG Cell Line by Aloe-Emodin through Generation of Reactive Oxygen Species and the Mitochondrial Pathway. Cell. Physiol. Biochem. 2017;42:685\u2013696. doi: 10.1159/000477886.", "ArticleIdList": ["10.1159/000477886", "28618413"]}, {"Citation": "Dong X., Fu J., Yin X., Yang C., Ni J. Aloe-emodin Induces Apoptosis in Human Liver HL-7702 Cells through Fas Death Pathway and the Mitochondrial Pathway by Generating Reactive Oxygen Species. Phytother Res. 2017;31:927\u2013936. doi: 10.1002/ptr.5820.", "ArticleIdList": ["10.1002/ptr.5820", "28444790"]}, {"Citation": "Quan Y., Gong L., He J., Zhou Y., Liu M., Cao Z., Li Y., Peng C. Aloe emodin induces hepatotoxicity by activating NF-kappaB inflammatory pathway and P53 apoptosis pathway in zebrafish. Toxicol. Lett. 2019;306:66\u201379. doi: 10.1016/j.toxlet.2019.02.007.", "ArticleIdList": ["10.1016/j.toxlet.2019.02.007", "30771440"]}, {"Citation": "Lim S., Lee S.J., Nam K.W., Kim K.H., Mar W. Hepatoprotective effects of reynosin against thioacetamide-induced apoptosis in primary hepatocytes and mouse liver. Arch. Pharm. Res. 2013;36:485\u2013494. doi: 10.1007/s12272-013-0039-0.", "ArticleIdList": ["10.1007/s12272-013-0039-0", "23435943"]}, {"Citation": "Qin C.Z., Lv Q.L., Wu N.Y., Cheng L., Chu Y.C., Chu T.Y., Hu L., Cheng Y., Zhang X., Zhou H.H. Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice. J. Ethnopharmacol. 2015;168:146\u2013149. doi: 10.1016/j.jep.2015.03.061.", "ArticleIdList": ["10.1016/j.jep.2015.03.061", "25858508"]}, {"Citation": "Wang L., He X., Jin C., Ondieki G. Mechanism-Based Inhibitors from Phytomedicine: Risks of Hepatotoxicity and their Potential Hepatotoxic Substructures. Curr. Drug Metab. 2016;17:971\u2013991. doi: 10.2174/1389200218666161123124253.", "ArticleIdList": ["10.2174/1389200218666161123124253", "27890005"]}, {"Citation": "Pizzo F., Lombardo A., Manganaro A., Benfenati E. A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts. Front. Pharmacol. 2016;7:442. doi: 10.3389/fphar.2016.00442.", "ArticleIdList": ["10.3389/fphar.2016.00442", "PMC5118449", "27920722"]}, {"Citation": "Zhang H., Ding L., Zou Y., Hu S.Q., Huang H.G., Kong W.B., Zhang J. Predicting drug-induced liver injury in human with Naive Bayes classifier approach. J. Comput. Aided Mol. Des. 2016;30:889\u2013898. doi: 10.1007/s10822-016-9972-6.", "ArticleIdList": ["10.1007/s10822-016-9972-6", "27640149"]}, {"Citation": "Benigni R., Bossa C. Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology. Mutat. Res. 2008;659:248\u2013261. doi: 10.1016/j.mrrev.2008.05.003.", "ArticleIdList": ["10.1016/j.mrrev.2008.05.003", "18621573"]}, {"Citation": "Ferrari T., Cattaneo D., Gini G., Golbamaki Bakhtyari N., Manganaro A., Benfenati E. Automatic knowledge extraction from chemical structures: The case of mutagenicity prediction. SAR QSAR Environ. Res. 2013;24:365\u2013383. doi: 10.1080/1062936X.2013.773376.", "ArticleIdList": ["10.1080/1062936X.2013.773376", "23710765"]}, {"Citation": "Lombardo A., Pizzo F., Benfenati E., Manganaro A., Ferrari T., Gini G. A new in silico classification model for ready biodegradability, based on molecular fragments. Chemosphere. 2014;108:10\u201316. doi: 10.1016/j.chemosphere.2014.02.073.", "ArticleIdList": ["10.1016/j.chemosphere.2014.02.073", "24875906"]}, {"Citation": "Teschke R., Genthner A., Wolff A. Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J. Ethnopharmacol. 2009;123:378\u2013384. doi: 10.1016/j.jep.2009.03.038.", "ArticleIdList": ["10.1016/j.jep.2009.03.038", "19501269"]}, {"Citation": "Gordon P., Khojasteh S.C. A decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: A case study of pennyroyal oil. Drug Metab. Rev. 2015;47:12\u201320. doi: 10.3109/03602532.2014.990032.", "ArticleIdList": ["10.3109/03602532.2014.990032", "25512112"]}, {"Citation": "Wei J., Zhang F., Zhang Y., Cao C., Li X., Li D., Liu X., Yang H., Huang L. Proteomic investigation of signatures for geniposide-induced hepatotoxicity. J. Proteome Res. 2014;13:5724\u20135733. doi: 10.1021/pr5007119.", "ArticleIdList": ["10.1021/pr5007119", "25336395"]}, {"Citation": "Yamano T., Tsujimoto Y., Noda T., Shimizu M., Ohmori M., Morita S., Yamada A. Hepatotoxicity of geniposide in rats. Food Chem. Toxicol. 1990;28:515\u2013519. doi: 10.1016/0278-6915(90)90122-4.", "ArticleIdList": ["10.1016/0278-6915(90)90122-4", "2210524"]}, {"Citation": "Garcia-Cortes M., Robles-Diaz M., Ortega-Alonso A., Medina-Caliz I., Andrade R.J. Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int. J. Mol. Sci. 2016;17:537. doi: 10.3390/ijms17040537.", "ArticleIdList": ["10.3390/ijms17040537", "PMC4848993", "27070596"]}, {"Citation": "Zarybnicky T., Bousova I., Ambroz M., Skalova L. Hepatotoxicity of monoterpenes and sesquiterpenes. Arch. Toxicol. 2018;92:1\u201313. doi: 10.1007/s00204-017-2062-2.", "ArticleIdList": ["10.1007/s00204-017-2062-2", "28905185"]}, {"Citation": "Federhen S. The NCBI Taxonomy database. Nucleic Acids Res. 2012;40:D136\u2013D143. doi: 10.1093/nar/gkr1178.", "ArticleIdList": ["10.1093/nar/gkr1178", "PMC3245000", "22139910"]}, {"Citation": "Letunic I., Bork P. Interactive Tree Of Life (iTOL) v4: Recent updates and new developments. Nucleic Acids Res. 2019;47:W256\u2013W259. doi: 10.1093/nar/gkz239.", "ArticleIdList": ["10.1093/nar/gkz239", "PMC6602468", "30931475"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Zhu F., Qin C., Tao L., Liu X., Shi Z., Ma X., Jia J., Tan Y., Cui C., Lin J., et al. Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting. Proc. Natl. Acad. Sci. USA. 2011;108:12943\u201312948. doi: 10.1073/pnas.1107336108.", "ArticleIdList": ["10.1073/pnas.1107336108", "PMC3150889", "21768386"]}, {"Citation": "Saslis-Lagoudakis C.H., Klitgaard B.B., Forest F., Francis L., Savolainen V., Williamson E.M., Hawkins J.A. The use of phylogeny to interpret cross-cultural patterns in plant use and guide medicinal plant discovery: An example from Pterocarpus (Leguminosae) PLoS ONE. 2011;6:e22275. doi: 10.1371/journal.pone.0022275.", "ArticleIdList": ["10.1371/journal.pone.0022275", "PMC3138776", "21789247"]}, {"Citation": "Saslis-Lagoudakis C.H., Savolainen V., Williamson E.M., Forest F., Wagstaff S.J., Baral S.R., Watson M.F., Pendry C.A., Hawkins J.A. Phylogenies reveal predictive power of traditional medicine in bioprospecting. Proc. Natl. Acad. Sci. USA. 2012;109:15835\u201315840. doi: 10.1073/pnas.1202242109.", "ArticleIdList": ["10.1073/pnas.1202242109", "PMC3465383", "22984175"]}, {"Citation": "Fu X., Song X., Li X., Wong K.K., Li J., Zhang F., Wang C., Wang Z. Phylogenetic Tree Analysis of the Cold-Hot Nature of Traditional Chinese Marine Medicine for Possible Anticancer Activity. Evid. Based Complement. Altern. Med. Ecam. 2017;2017:4365715. doi: 10.1155/2017/4365715.", "ArticleIdList": ["10.1155/2017/4365715", "PMC5278566", "28191021"]}, {"Citation": "Brown A.C. Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series. Food Chem. Toxicol. 2017;107:502\u2013519. doi: 10.1016/j.fct.2016.07.024.", "ArticleIdList": ["10.1016/j.fct.2016.07.024", "28755953"]}, {"Citation": "Brown A.C. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food Chem. Toxicol. 2017;107:472\u2013501. doi: 10.1016/j.fct.2016.07.001.", "ArticleIdList": ["10.1016/j.fct.2016.07.001", "27402097"]}, {"Citation": "Lee J.Y., Jun S.A., Hong S.S., Ahn Y.C., Lee D.S., Son C.G. Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials. Phytother Res. 2016;30:1412\u20131419. doi: 10.1002/ptr.5647.", "ArticleIdList": ["10.1002/ptr.5647", "27196988"]}, {"Citation": "Brown A.C. Heart Toxicity Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 4 of 5. J. Diet. Suppl. 2018;15:516\u2013555. doi: 10.1080/19390211.2017.1356418.", "ArticleIdList": ["10.1080/19390211.2017.1356418", "28981338"]}, {"Citation": "Brown A.C. Cancer Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 5 of 5. J. Diet. Suppl. 2018;15:556\u2013581. doi: 10.1080/19390211.2017.1355865.", "ArticleIdList": ["10.1080/19390211.2017.1355865", "28981366"]}, {"Citation": "Saini N., Bakshi S., Sharma S. In-silico approach for drug induced liver injury prediction: Recent advances. Toxicol. Lett. 2018;295:288\u2013295. doi: 10.1016/j.toxlet.2018.06.1216.", "ArticleIdList": ["10.1016/j.toxlet.2018.06.1216", "29981923"]}, {"Citation": "Chen M., Bisgin H., Tong L., Hong H., Fang H., Borlak J., Tong W. Toward predictive models for drug-induced liver injury in humans: Are we there yet? Biomark. Med. 2014;8:201\u2013213. doi: 10.2217/bmm.13.146.", "ArticleIdList": ["10.2217/bmm.13.146", "24521015"]}, {"Citation": "Wetzel S., Schuffenhauer A., Roggo S., Ertl P., Waldmann H. Cheminformatic Analysis of Natural Products and their Chemical Space. CHIMIA Int. J. Chem. 2007;61:355\u2013360. doi: 10.2533/chimia.2007.355.", "ArticleIdList": ["10.2533/chimia.2007.355"]}, {"Citation": "Stratton C.F., Newman D.J., Tan D.S. Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorg. Med. Chem. Lett. 2015;25:4802\u20134807. doi: 10.1016/j.bmcl.2015.07.014.", "ArticleIdList": ["10.1016/j.bmcl.2015.07.014", "PMC4607632", "26254944"]}, {"Citation": "Zhu Y.L., Zu-Guang Y.E. Computational toxicology and its application in toxicity study of traditional Chinese medicine. Chin. J. New Drugs. 2011;20:2424\u20132429."}, {"Citation": "Ai H., Chen W., Zhang L., Huang L., Yin Z., Hu H., Zhao Q., Zhao J., Liu H. Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints. Toxicol. Sci. 2018;165:100\u2013107. doi: 10.1093/toxsci/kfy121.", "ArticleIdList": ["10.1093/toxsci/kfy121", "29788510"]}, {"Citation": "Zhao P., Liu B., Wang C. Hepatotoxicity evaluation of traditional Chinese medicines using a computational molecular model. Clin. Toxicol. 2017;55:996\u20131000. doi: 10.1080/15563650.2017.1333123.", "ArticleIdList": ["10.1080/15563650.2017.1333123", "28594241"]}, {"Citation": "Villa F.A., Gerwick L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacol. Immunotoxicol. 2010;32:228\u2013237. doi: 10.3109/08923970903296136.", "ArticleIdList": ["10.3109/08923970903296136", "20441539"]}, {"Citation": "Baker D.D., Chu M., Oza U., Rajgarhia V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep. 2007;24:1225\u20131244. doi: 10.1039/b602241n.", "ArticleIdList": ["10.1039/b602241n", "18033577"]}, {"Citation": "Mishra B.B., Tiwari V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011;46:4769\u20134807. doi: 10.1016/j.ejmech.2011.07.057.", "ArticleIdList": ["10.1016/j.ejmech.2011.07.057", "21889825"]}, {"Citation": "Kitada S., Kress C.L., Krajewska M., Jia L., Pellecchia M., Reed J.C. Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048) Blood. 2008;111:3211\u20133219. doi: 10.1182/blood-2007-09-113647.", "ArticleIdList": ["10.1182/blood-2007-09-113647", "PMC2265458", "18202226"]}, {"Citation": "Feng Z., Zhou C., Dong S., Liu Z., Liu T., Zhou L., Zhou X. Catalpol and panax notoginseng saponins synergistically alleviate triptolide-induced hepatotoxicity through Nrf2/ARE pathway. Toxicol. In Vitro. 2019;56:141\u2013149. doi: 10.1016/j.tiv.2019.01.016.", "ArticleIdList": ["10.1016/j.tiv.2019.01.016", "30682494"]}, {"Citation": "Li W., Yin H., Bardelang D., Xiao J., Zheng Y., Wang R. Supramolecular formulation of nitidine chloride can alleviate its hepatotoxicity and improve its anticancer activity. Food Chem. Toxicol. 2017;109:923\u2013929. doi: 10.1016/j.fct.2017.02.022.", "ArticleIdList": ["10.1016/j.fct.2017.02.022", "28223120"]}, {"Citation": "Liu C., Fan H., Li Y., Xiao X. Research Advances on Hepatotoxicity of Herbal Medicines in China. Biomed. Res. Int. 2016;2016:7150391. doi: 10.1155/2016/7150391.", "ArticleIdList": ["10.1155/2016/7150391", "PMC5203888", "28078299"]}, {"Citation": "Stine J.G., Lewis J.H. Current and future directions in the treatment and prevention of drug-induced liver injury: A systematic review. Expert Rev. Gastroenterol. Hepatol. 2016;10:517\u2013536. doi: 10.1586/17474124.2016.1127756.", "ArticleIdList": ["10.1586/17474124.2016.1127756", "PMC5074808", "26633044"]}]}], "History": [{"Year": "2019", "Month": "5", "Day": "21"}, {"Year": "2019", "Month": "7", "Day": "8"}, {"Year": "2019", "Month": "7", "Day": "18"}, {"Year": "2019", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31349548", "PMC6695972", "10.3390/ijms20153633", "ijms20153633"]}}]}